PWS
VRTX icon

Pursuit Wealth Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Pursuit Wealth Strategies’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Sell
517
-17
-3% -$7.93K 0.32% 68
2025
Q4 		$242K Buy
+534
New +$230K 0.34% 62

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pursuit Wealth Strategies's VRTX Position: Q1 2026 in Review

Pursuit Wealth Strategies reduced its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q1 2026, selling an estimated $7.93K and leaving 517 shares worth $231K. The position accounts for 0.32% of the portfolio, ranked #68.

Pursuit Wealth Strategies first reported a position in VRTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $242K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Pursuit Wealth Strategies held 517 shares of Vertex Pharmaceuticals worth $231K as of Q1 2026.
  • Pursuit Wealth Strategies sold 17 Vertex Pharmaceuticals shares in Q1 2026, an estimated $7.93K.
  • Vertex Pharmaceuticals made up 0.32% of Pursuit Wealth Strategies's portfolio in Q1 2026, its #68 holding.
  • Pursuit Wealth Strategies first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Pursuit Wealth Strategies's Vertex Pharmaceuticals position peaked at $242K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Pursuit Wealth Strategies's 13F filing for Q1 2026, filed 15 May 2026.